|
Wed, 12/08/2010
Immediately Doubles Manufacturing Capacity Healthpoint today announced that the U.S. Food and Drug Administration has granted approval to manufacture commercial supplies of Collagenase SANTYL® Ointment, a biologic enzymatic debriding agent, at DPT Laboratories’ Center of Excellence for Sterile & Specialty Products facility in Lakewood, New Jersey. DPT Laboratories is one of Healthpoint’s contract manufacturers for the brand. |
||
Mon, 10/25/2010
Visit www.outlastgerms.com for more information. |
||
Fri, 10/01/2010
Healthpoint today announced that the results of a new study conducted by Catherine T. Milne APRN, MSN, CWOCN, BC-ANP, will be presented on Thursday, September 30, 2010 at 7:15pm (Eastern) at the Healthpoint booth (#110) during the 25th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing. |
||
Tue, 08/10/2010
Healthpoint today announced that it has initiated a clinical trial assessing the effectiveness of Collagenase SANTYL® Ointment, as compared to vehicle, on the change from baseline in wound area of diabetic foot ulcers (DFU) over four weeks. The trial will also follow subjects to determine the proportion that achieve complete wound closure within 12 weeks of initiating treatment. One of the long-term complications of diabetes is the development of foot ulcers primarily as a consequence of peripheral neuropathy due to prolonged serum glucose elevation. |
||
|
Tue, 03/30/2010
Healthpoint, Ltd., a Fort Worth-based company committed to advancing the science and innovation of wound care, was recently named to Training Magazine’s Top 125 List for 2010. This is the first year that Healthpoint applied to be named to the Training Top 125, finishing 104 among all companies. The 2010 Training Top 125 is an annual ranking that honors organizations that offer outstanding employer-sponsored workforce training and development. Other companies recognized in the Top 125 include Microsoft, Cisco, Bank of America, and the US Navy. |
